Details of the Drug

General Information of Drug (ID: DMHTIBR)

Drug Name
TAK-951
Indication
Disease Entry ICD 11 Status REF
Nausea and vomiting MD90 Phase 2 [1]
Cross-matching ID
TTD ID
D31XQD

References

1 ClinicalTrials.gov (NCT04557189) A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects. U.S.National Institutes of Health.